These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 2956138

  • 1. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
    Nappi C, Farace MJ, Leone F, Minutolo M, Tommaselli AP, Montemagno U.
    Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138
    [Abstract] [Full Text] [Related]

  • 2. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
    Siegberg R, Nilsson CG, Stenman UH, Widholm O.
    Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
    [Abstract] [Full Text] [Related]

  • 3. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
    Mango D, Ricci S, Manna P, Miggiano GA, Serra GB.
    Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881
    [Abstract] [Full Text] [Related]

  • 4. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R, Reinilä M, Kivinén S.
    Acta Derm Venereol; 1986 Mar; 66(3):225-30. PubMed ID: 2426899
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol.
    Cullberg G.
    Acta Obstet Gynecol Scand Suppl; 1985 Mar; 133():1-30. PubMed ID: 3161265
    [Abstract] [Full Text] [Related]

  • 6. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.
    Venturoli S, Porcu E, Gammi L, Fabbri R, Paradisi R, Flamigni C, Patrono D, Capelli M, Paoletti C.
    Acta Eur Fertil; 1988 Mar; 19(3):129-34. PubMed ID: 2976224
    [Abstract] [Full Text] [Related]

  • 7. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Wiegratz I, Jung-Hoffmann C, Kuhl H.
    Contraception; 1995 Jun; 51(6):341-6. PubMed ID: 7554973
    [Abstract] [Full Text] [Related]

  • 8. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R.
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [Abstract] [Full Text] [Related]

  • 9. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P.
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [Abstract] [Full Text] [Related]

  • 10. The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
    Ruutiainen K.
    Int J Gynaecol Obstet; 1986 Oct; 24(5):361-8. PubMed ID: 2880770
    [Abstract] [Full Text] [Related]

  • 11. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 12. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L, Galbignani E.
    Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
    [Abstract] [Full Text] [Related]

  • 13. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Dec; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A, Dewailly SD, Grenier R, Huard J.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [Abstract] [Full Text] [Related]

  • 15. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 16. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    Gaspard UJ, Dubois M, Gillain D, Franchimont P, Duvivier J.
    Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
    [Abstract] [Full Text] [Related]

  • 17. Effects of combined ethinylestradiol and desogestrel on hormone profiles and sex hormone binding globulin in women with polycystic ovarian disease.
    Rojanasakul A, Sirimongkolkasem R, Piromsawasdi S, Sumavong V, Chailurkit L, Chaturachinda K.
    Contraception; 1987 Dec; 36(6):633-40. PubMed ID: 2965636
    [Abstract] [Full Text] [Related]

  • 18. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM, Fauser BC.
    Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
    [Abstract] [Full Text] [Related]

  • 19. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.
    Castelo-Branco C, Martínez de Osaba MJ, Pons F, Fortuny A.
    Metabolism; 1997 Apr; 46(4):437-40. PubMed ID: 9109850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.